SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001141
Filing Date
2022-05-04
Accepted
2022-05-04 16:18:23
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pahc-20220331x10q.htm   iXBRL 10-Q 2026768
2 EXHIBIT 31.1 pahc-20220331xex31d1.htm EX-31.1 7387
3 EXHIBIT 31.2 pahc-20220331xex31d2.htm EX-31.2 8124
4 EXHIBIT 32.1 pahc-20220331xex32d1.htm EX-32.1 3408
5 EXHIBIT 32.2 pahc-20220331xex32d2.htm EX-32.2 4149
  Complete submission text file 0001410578-22-001141.txt   7591104

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20220331.xsd EX-101.SCH 36046
7 EX-101.CAL pahc-20220331_cal.xml EX-101.CAL 64537
8 EX-101.DEF pahc-20220331_def.xml EX-101.DEF 162742
9 EX-101.LAB pahc-20220331_lab.xml EX-101.LAB 305115
10 EX-101.PRE pahc-20220331_pre.xml EX-101.PRE 272303
53 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20220331x10q_htm.xml XML 1639764
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 22891748
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences